Skip to main content
. Author manuscript; available in PMC: 2014 Nov 15.
Published in final edited form as: J Immunol. 2013 Oct 11;191(10):10.4049/jimmunol.1300456. doi: 10.4049/jimmunol.1300456

Figure 6. BC-1215 reduces DSS induced colonic inflammation.

Figure 6

A–E. C57BL6 mice were fed with water ad lib containing 3.5% dextran sulfate sodium (DSS) for up to five days. Mice were treated with either vehicle (control [CON]) or BC-1215 (100 µg) daily (via an i.p. injection). Mice were then euthanized and the length of the colon was measured and graphed in (A). Colonic tissues were also analysed for IL1β (B), TNFα (C) and TRAF proteins by immunoblotting (D). E. H&E and Alcian blue staining were performed on colonic sections. The data represent n=4 mice/group, *P<0.05 versus DSS and **P<0.05 versus CON).